About us

For Authors

For Reviewers

Cover gallery

For Copy-editors

General information

Published by Springer on behalf of the European Association for the Study of Diabetes (EASD)
Scope: Diabetologia publishes original clinical and experimental research within the field of diabetes
Editor-in-Chief: Juleen Zierath
Managing Editor: Judy Naylor
ISI Journal Citation Reports Ranking: 11 out of 123 in Endocrinology and Metabolism
Impact Factor (2013): 6.88
Frequency: 12 issues a year
Acceptance rate: <20 per cent
Free online access to all articles after 12 months - click here to access the online journal
Circulation: >8,300 institutions have access
Online access for EASD members: Since January 2014, access to Diabetologia for EASD members has been exclusively electronic and members no longer receive a print copy of the journal. Please see the letter from the EASD, which includes details of how to access Diabetologia articles.

Back to top

Services to authors

Online submissions: http://mc.manuscriptcentral.com/diabetologia
Submission fee: none
Page charges: none
Rapid triage system: allows authors to submit to a more appropriate journal without delay
Open access: authors have the option to make their paper freely available immediately after publication (see Springer's Open Choice program)

Back to top

Frequently asked questions




How do I subscribe to Diabetologia?

Membership of the EASD includes online access to Diabetologia. Membership is available to students, individuals holding a medical degree or scientific workers with an academic degree. To join the EASD, please visit their membership page
Alternatively, you can subscribe to Diabetologia via our publisher, Springer:
by email: subscriptions@springer.com
on their website
by telephone: +49(6221)3454242



How do I sign up for the Table of Content alert?

Enter your email address in the 'Alerts for this journal' box on the right-hand side of the Diabetologia page on springer.com: http://www.springer.com/medicine/internal/journal/125



Does posting an electronic copy of a PhD thesis in an open access repository violate Diabetologia's exclusivity policy and preclude publication in Diabetologia?

No



My study was funded in whole or in part by one of the UK's Research Councils (RCUK). All accepted papers submitted after April 2013 must be published in journals that are compliant with the Research Councils' Open Access policy. Is Diabetologia compliant with this policy?

Yes. Authors must select Springer's Open Choice program ($3,000 USD) then Springer will immediately deposit the final published article in PubMed Central where it will be available immediately. This will involve payment of an 'Article Processing Charge' to the publisher after acceptance of the paper. In line with RCUK policy, the paper will be published under the Creative Commons Attribution (CC BY) license which lets others modify, build upon and/or distribute the licensed work (including for commercial purposes) as long as the original author is credited. Springer will deposit the final published version of your article into PubMed Central and make it freely available at the time of publication.


My study was funded by NIH and I have to submit my accepted article to PubMed Central. How do I do this?

There are two options:

  1. If you opt for Springer's Open Choice program ($3,000 USD) then Springer will immediately deposit the final published article in PubMed Central where it will be available immediately. For further information see Springer's NIH Compliance Policy
  2. If you do not wish to pay for Open Choice then you may (a) submit your article to PubMed Central yourself - see http://publicaccess.nih.gov/submit_process.htm for instructions. You can submit your final author's version to PubMed Central immediately upon publication, but it will only be made publicly available 12 months after publication. Please note that the publisher's pdf version cannot be deposited on PubMed Central. Or (b) notify Springer within the 'MyPublication process' to deposit the author's accepted version of your article into the NIH Manuscript Submission System, from where it will be sent to PubMed Central and made publicly available 12 months after publication. Springer will upload the accepted manuscript version of your article to the NIH Manuscript Submission System (NIHMS). Note that the uploaded article version corresponds to the final manuscript after peer-review and thus, does not include any corrections you will carry out at a later stage (e.g. during proofing). Once your article is uploaded, you will receive email notification from NIHMS, asking you for approval of the upload to PubMed Central. When you have approved the upload, a web version of the article will be created by PubMed Central. Upon your approval of the web version, the PMCID will be created and can be found in the NIHMS. As soon as the article is displayed at PubMed Central, you will be able to find the PMCID by searching for your article.
    For further information see Springer's NIH Compliance Policy



My study was funded by Wellcome Trust. The Trust requires papers to be made available on PubMed Central as soon as possible after publication, and certainly within six months of the publication date. How do I do this?

Please select Springer's Open Choice program ($3,000 USD) then Springer will immediately deposit the final published article in PubMed Central where it will be available immediately. For further information see Springer's Wellcome Trust Compliance Policy. The cost of having your article published with open access is covered by the Wellcome Trust. Please see the Wellcome Trust's Authors' Guide for details. In line with the Wellcome Trust policy affecting papers submitted after 1st April 2013, articles will be published under the Creative Commons Attribution (CC BY) license which lets others modify, build upon and/or distribute the licensed work (including for commercial purposes) as long as the original author is credited (see the CC-BY FAQ for more information)


How do I order reprints of an article published in Diabetologia?

All reprint orders are handled via our publisher's website. Please go to http://www.springerlink.com/content/0012-186X and locate the article you are interested in. Go to the article's abstract and click on the "Permissions & Reprints" button on the right-hand side. Simply answer the on-screen questions to order reprints. If you have problems completing the order online, please email permissions.dordrecht@springer.com



How do I request permission to reproduce material published in Diabetologia?

All permission requests are handled via our publisher's website. Please go to http://www.springerlink.com/content/0012-186X and locate the article you are interested in. Go to the article's abstract and click on the "Permissions & Reprints" button on the right-hand side. Simply answer the on-screen questions to request the permission you require. For further information please see http://www.springer.com/rights?SGWID=0-122-12-372399-0. If you have problems completing the permission online, please email permissions.heidelberg@springer.com



Does Diabetologia publish supplements?

The only supplement published is the Abstract volume of the annual EASD meeting



How do I advertise in Diabetologia?

Please contact Springer's advertising department: tel: +49 (0)30 82 787 5731; e-mail raina.chandler@springer.com



How do I become a referee for Diabetologia?

As a first step we would ask you to add your details and an accurate record of your areas of interest to our database. Please go to http://mc.manuscriptcentral.com/diabetologia and click on the 'Create account' button in the top right-hand corner of the screen. Follow the on-screen instructions to create an account and select only the keywords that best describe your main research interests
Please be aware that even after you have created an account you may not be asked to serve as a referee as we have a very large pool of expert reviewers and our Associate Editors strive to find a good match between the referees' expertise and the paper under review
We are often contacted by scientists keen to review for us and are sorry not to be able to make any guarantees

Back to top